{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T20:10:17Z","timestamp":1790712617920,"version":"4.1.0"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"name":"Direction G\u00e9n\u00e9rale de l'Offre de Soins","award":["PREPS - 13-0531"],"award-info":[{"award-number":["PREPS - 13-0531"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Geriatr"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s12877-017-0600-7","type":"journal-article","created":{"date-parts":[[2017,8,30]],"date-time":"2017-08-30T08:13:54Z","timestamp":1504080834000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["A multi-center, randomized, controlled trial to assess the efficacy of optimization of drug prescribing in an elderly population, at 18\u00a0months of follow-up, in the evolution of functional autonomy: the OPTIM study protocol"],"prefix":"10.1186","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5020-2864","authenticated-orcid":false,"given":"Virginie","family":"Dauphinot","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elodie","family":"Jean-Bart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Krolak-Salmon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christelle","family":"Mouchoux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,8,30]]},"reference":[{"key":"600_CR1","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S0140-6736(07)61091-5","volume":"370","author":"A Spinewine","year":"2007","unstructured":"Spinewine A, Schmader K, Barber B, et al. Appropriate prescribing in elderdly people: how well can it be measured and optimised? Lancet. 2007;370:173\u201384.","journal-title":"Lancet"},{"key":"600_CR2","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/j.revmed.2004.02.027","volume":"25","author":"S Ferchichi","year":"2004","unstructured":"Ferchichi S, Antoine V. Le bon usage du m\u00e9dicament chez la personne \u00e2g\u00e9e. Rev Med Interne. 2004;25:582\u201390.","journal-title":"Rev Med Interne"},{"key":"600_CR3","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1136\/bmj.315.7115.1057","volume":"315","author":"C Mannese","year":"1997","unstructured":"Mannese C, Derkx F, de Ridder M, Man in\u2019t Veld A, van der Cammen T. Adverse drug reactions in the elderdy patients as contributing factor for hospitalisation admission: cross sectionnal study. BMJ. 1997;315:1057\u20138.","journal-title":"BMJ"},{"issue":"13","key":"600_CR4","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1001\/archinte.161.13.1629","volume":"161","author":"TS Field","year":"2001","unstructured":"Field TS, Gurwitz JH, Avorn J, et al. Risk factors for adverse drug events among nursing home residents. Arch Int Med. 2001;161(13):1629\u201334.","journal-title":"Arch Int Med"},{"issue":"8","key":"600_CR5","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1016\/j.clinthera.2006.08.006","volume":"28","author":"C Lindblad","year":"2006","unstructured":"Lindblad C, Hanlon J, Gross C, et al. Clinically important drug-disease interactions and their prevalence in older adults. Clin Ther. 2006;28(8):1133\u201343.","journal-title":"Clin Ther"},{"issue":"11","key":"600_CR6","doi-asserted-by":"crossref","first-page":"817","DOI":"10.2165\/00002512-200320110-00003","volume":"20","author":"V Rollason","year":"2003","unstructured":"Rollason V, Vogt N. Reduction of polypharmacy in the elderly. Drugs Aging. 2003;20(11):817\u201332.","journal-title":"Drugs Aging"},{"issue":"11","key":"600_CR7","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1001\/jama.293.11.1348","volume":"293","author":"D Fialova","year":"2005","unstructured":"Fialova D, Topinkova E, Gambassi G, et al. Potentially inappropriate medication use among elderly home care patients in Europe. JAMA. 2005;293(11):1348\u201358.","journal-title":"JAMA"},{"issue":"2","key":"600_CR8","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.cger.2012.01.005","volume":"28","author":"BK Tamura","year":"2012","unstructured":"Tamura BK, Bell CL, Inaba M, Masaki KH. Ouctomes of polypharmacy in nursing home residents. Clin Geriatr Med. 2012;28(2):217\u201336.","journal-title":"Clin Geriatr Med"},{"key":"600_CR9","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1186\/1471-2458-13-115","volume":"13","author":"D Gnjidic","year":"2013","unstructured":"Gnjidic D, Le Couteur DG, Pearson SA, et al. High risk prescribing in older adults: prevalence, clinical and economic implications and potential for intervention at the population level. BMC Public Health. 2013;13:115.","journal-title":"BMC Public Health"},{"key":"600_CR10","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1002\/pds.1762","volume":"18","author":"B Bongue","year":"2009","unstructured":"Bongue B, Naudin F, Laroche M, et al. Trends of the potentially inappropriate medication consumption over 10 years in older adults in the East of France. Pharmacoepi Drug Saf. 2009;18:1125\u201333.","journal-title":"Pharmacoepi Drug Saf"},{"issue":"1","key":"600_CR11","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1345\/aph.1D313","volume":"38","author":"J Hanlon","year":"2004","unstructured":"Hanlon J, Artz M, Pieper C, et al. Inappropriate medication use among frail elderly inpatients. Ann Pharmacother. 2004;38(1):9\u201314.","journal-title":"Ann Pharmacother"},{"key":"600_CR12","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1001\/jama.279.15.1200","volume":"279","author":"J Lazarou","year":"1998","unstructured":"Lazarou J, Pomeranz B, Corey P. Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies. JAMA. 1998;279:1200\u20135.","journal-title":"JAMA"},{"key":"600_CR13","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1056\/NEJM199102073240604","volume":"324","author":"T Brennan","year":"1991","unstructured":"Brennan T, Leape L, Laird N. Incidence of adverse events and negligence in hospitalized patients: results of the Harvard medical practice study (I). NEJM. 1991;324:370\u20136.","journal-title":"NEJM"},{"key":"600_CR14","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1001\/jama.1994.03520040054040","volume":"272","author":"S Willcox","year":"1994","unstructured":"Willcox S, Himmelstein D, Woolhandler S. Inappropriate drug prescribing for the community-dwelling elderly. JAMA. 1994;272:292\u20136.","journal-title":"JAMA"},{"issue":"9","key":"600_CR15","doi-asserted-by":"crossref","first-page":"714","DOI":"10.7326\/0003-4819-140-9-200405040-00011","volume":"140","author":"T Higashi","year":"2004","unstructured":"Higashi T, Shekelle P, Solomon D, et al. The quality of pharmacologic care for vulnerable older patients. Ann Intern Med. 2004;140(9):714\u201320.","journal-title":"Ann Intern Med"},{"issue":"18","key":"600_CR16","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.1001\/archinte.163.18.2165","volume":"163","author":"A Feldstein","year":"2003","unstructured":"Feldstein A, Elmer P, Orwoll E, Herson M, Hillier T. Bone mineral density measurement and treatment of osteoporosis in older individuals with fractures: a gap in evidence-bases practice guideline implemetation. Arch Intern Med. 2003;163(18):2165\u201372.","journal-title":"Arch Intern Med"},{"issue":"2","key":"600_CR17","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1097\/00005650-200202000-00011","volume":"40","author":"J Hanlon","year":"2002","unstructured":"Hanlon J, Fillenbaum G, Kuchibhatla M, et al. Impact of inappropriate drug use on mortality and functional status in representative community dwelling elders. Med Care. 2002;40(2):166\u201376.","journal-title":"Med Care"},{"key":"600_CR18","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/S1543-5946(04)90014-1","volume":"2","author":"G Fillenbaum","year":"2004","unstructured":"Fillenbaum G, Hanlon J, Landerman L, et al. Impact of inappropriate drug use on health services utilization among representative older community-dwelling residents. Am J Geriatr Pharmacother. 2004;2:92\u2013101.","journal-title":"Am J Geriatr Pharmacother"},{"issue":"9","key":"600_CR19","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/1471-2318-9-30","volume":"23","author":"S Berdot","year":"2009","unstructured":"Berdot S, Bertrand M, Dartigues JF, et al. Inappropriate medication use and risk of falls - a prospective study in a large community-dwelling elderly cohort. BMC Geriatr. 2009;23(9):30.","journal-title":"BMC Geriatr"},{"issue":"3","key":"600_CR20","doi-asserted-by":"crossref","first-page":"426","DOI":"10.3109\/08923970903468847","volume":"32","author":"MT Ventura","year":"2010","unstructured":"Ventura MT, Laddaga R, Cavallera P, et al. Adverse drug reactions as the cause of emergency department admission: focus on the elderly. Immunopharmacol Immunotoxicol. 2010;32(3):426\u20139.","journal-title":"Immunopharmacol Immunotoxicol"},{"issue":"11","key":"600_CR21","doi-asserted-by":"crossref","first-page":"755","DOI":"10.7326\/0003-4819-147-11-200712040-00006","volume":"147","author":"DS Budnitz","year":"2007","unstructured":"Budnitz DS, Shehab N, Kegler SR, Richards CL. Medication use leading to emergency department visits for adverse drug events in older adults. Ann Intern Med. 2007;147(11):755\u201365.","journal-title":"Ann Intern Med"},{"issue":"2","key":"600_CR22","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.respe.2011.10.004","volume":"60","author":"M Jardin","year":"2012","unstructured":"Jardin M, Bocquier A, Cortaredona S, et al. Potentially inappropriate prescriptions for the elderly: a study of health insurance reimbursements in southeastern France. Rev Epidemiol Sante Publique. 2012;60(2):121\u201330.","journal-title":"Rev Epidemiol Sante Publique"},{"issue":"9","key":"600_CR23","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1001\/jama.289.9.1107","volume":"289","author":"JH Gurwitz","year":"2003","unstructured":"Gurwitz JH, Field TS, Harrold LR, et al. Incidence and preventability of adverse drug events among older persons in the ambulatory setting. JAMA. 2003;289(9):1107\u201316.","journal-title":"JAMA"},{"key":"600_CR24","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1001\/archinte.167.8.781","volume":"167","author":"S Hilmer","year":"2007","unstructured":"Hilmer S, Mager D, Simonsick E, et al. A drug burden index to define the functional burden of medications in older people. Arch Intern Med. 2007;167:781\u20137.","journal-title":"Arch Intern Med"},{"issue":"2","key":"600_CR25","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1097\/JCP.0b013e3182487825","volume":"32","author":"D Gnjidic","year":"2012","unstructured":"Gnjidic D, Le Couteur DG, Naganathan V, et al. Effects of drug burden index on cognitive function in older men. J Clin Phychopharmacol. 2012;32(2):273\u20137.","journal-title":"J Clin Phychopharmacol"},{"issue":"7","key":"600_CR26","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1002\/pds.3624","volume":"23","author":"PS Nishtala","year":"2014","unstructured":"Nishtala PS, Narayan SW, Wang T, Hilmer SN. Associations of drug burden index with falls, general practitioner visits, and mortality in older people. Pharmacoepidemiol Drug Saf. 2014;23(7):753\u20138.","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"3","key":"600_CR27","doi-asserted-by":"crossref","first-page":"195","DOI":"10.2165\/11586580-000000000-00000","volume":"28","author":"M Fortin","year":"2011","unstructured":"Fortin M, Rouch I, Dauphinot V, et al. Effects of anticholinergic drugs on verbal episodic memory function in the elderly: a retrospective, cross-sectional study. Drugs Aging. 2011;28(3):195\u2013204.","journal-title":"Drugs Aging"},{"issue":"5","key":"600_CR28","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1097\/JCP.0000000000000195","volume":"34","author":"V Dauphinot","year":"2014","unstructured":"Dauphinot V, Faure R, Omrani S, et al. Exposure to anticholinergic and sedative drugs, risk of falls, and mortality: an elderly inpatient, multicenter cohort. J Clin Psychopharmacol. 2014;34(5):565\u201370.","journal-title":"J Clin Psychopharmacol"},{"issue":"14","key":"600_CR29","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1001\/archinternmed.2009.229","volume":"169","author":"I Carriere","year":"2009","unstructured":"Carriere I, Fourrier-Reglat A, Dartigues J, et al. Drugs with anticholinergic properties, cognitive decline, and dementia in an elderly general population: the 3-city study. Arch Intern Med. 2009;169(14):1317\u201324.","journal-title":"Arch Intern Med"},{"key":"600_CR30","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1345\/aph.1L700","volume":"43","author":"R Castelino","year":"2009","unstructured":"Castelino R, Bajorek B, Chen T. Targeing suboptimal prescribing in the elderly: a review of the impact of pharmacy services. Ann Pharmacother. 2009;43:1096\u2013106.","journal-title":"Ann Pharmacother"},{"issue":"12","key":"600_CR31","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.2165\/11318890-000000000-00000","volume":"26","author":"S Kaur","year":"2009","unstructured":"Kaur S, Mitchell G, Vitetta L, Roberts M. Interventions that can reduce inapproprate prescribing in the elderly. Drugs Aging. 2009;26(12):1013\u201328.","journal-title":"Drugs Aging"},{"issue":"6","key":"600_CR32","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1111\/j.1365-2125.2004.02220.x","volume":"58","author":"L Sorensen","year":"2004","unstructured":"Sorensen L, Stokes J, Purdie D, Woodward M, Elliott R, Roberts M. Medication reviews in the community: results of a randomized, controlled effectiveness trial. Br J Clin Pharmacol. 2004;58(6):648\u201364.","journal-title":"Br J Clin Pharmacol"},{"key":"600_CR33","doi-asserted-by":"crossref","unstructured":"Christensen M, Lundh A. Medication review in hospitalised patients to reduce morbidity and mortality. Cochrane Database Syst Rev. 2016;2","DOI":"10.1002\/14651858.CD008986.pub3"},{"issue":"3","key":"600_CR34","doi-asserted-by":"crossref","first-page":"265","DOI":"10.2165\/00019053-200624030-00006","volume":"24","author":"J Hill","year":"2006","unstructured":"Hill J, Fillit H, Thomas S, Chang S. Functional impairment, healthcare costs and the prevalence of institutionalisation in patients with Alzheimer's disease and other dementias. PharmacoEconomics. 2006;24(3):265\u201380.","journal-title":"PharmacoEconomics"},{"issue":"3","key":"600_CR35","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1093\/ageing\/afj059","volume":"35","author":"M Soto","year":"2006","unstructured":"Soto M, Andrieu S, Gillette-Guyonnet S, Cantet C, Nourhashemi F, Vellas B. Risk factors for functionnal decline and institutionalisation among community-dwelling older adults with mild to severe Alzheimer's disease: one year of follow-up. Age Ageing. 2006;35(3):308\u201310.","journal-title":"Age Ageing"},{"issue":"3","key":"600_CR36","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1007\/BF03324602","volume":"17","author":"K P\u00e9r\u00e8s","year":"2005","unstructured":"P\u00e9r\u00e8s K, Helmer C, Letenneur L, Jacqmim-Gadda H, Barberger-Gateau P. Ten-year change in disability prevalence and related factors in two generations of French elderly community dwellers: data from the PAQUID study. Aging Clin Exp Res. 2005;17(3):229\u201335.","journal-title":"Aging Clin Exp Res"},{"issue":"6","key":"600_CR37","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.amjopharm.2011.10.002","volume":"9","author":"EP Peron","year":"2011","unstructured":"Peron EP, Gray SL, Hanlon JT. Medication use and functional status decline in older adults: a narrative review. Am J Geriatr Pharmacother. 2011;9(6):378\u201391.","journal-title":"Am J Geriatr Pharmacother"},{"issue":"3","key":"600_CR38","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0022-3956(75)90026-6","volume":"12","author":"M Folstein","year":"1975","unstructured":"Folstein M, Folstein S, et al. \u201cMini-mental state\u201d. A practical method for grading the cognitive stade of patients for the clinician. J Psychiatr Res. 1975;12(3):189\u201398.","journal-title":"J Psychiatr Res"},{"issue":"3","key":"600_CR39","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/BF00435221","volume":"2","author":"J Brazier","year":"1993","unstructured":"Brazier J, Jones N, Kind P. Testing the validity of the Euroqol and comparing it with the SF-36 health survey questionnaire. Qual Life Res. 1993;2(3):169\u201380.","journal-title":"Qual Life Res"},{"issue":"2","key":"600_CR40","first-page":"91","volume":"23","author":"JP Cl\u00e9ment","year":"1997","unstructured":"Cl\u00e9ment JP, Nassif RF, L\u00e9ger JM, Marchan F. Development and contribution to the validation of a brief French version of the Yesavage geriatric depression scale. Enc\u00e9phale. 1997;23(2):91\u20139.","journal-title":"Enc\u00e9phale"},{"issue":"1","key":"600_CR41","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/j.2044-8341.1959.tb00467.x","volume":"32","author":"M Hamilton","year":"1959","unstructured":"Hamilton M. The assessment of anxiety states by rating. Br J Med Psychol. 1959;32(1):50\u20135.","journal-title":"Br J Med Psychol"},{"key":"600_CR42","first-page":"1044","volume":"30","author":"X Girerd","year":"2001","unstructured":"Girerd X, Hanon O, Anangnostopoulos K, Cirepek L, Mourad J, Consolis. Evaluation de l'observance du traitement antihypertenseur par un questionnaire : mise au point et utilisation dans un service sp\u00e9cialis\u00e9. Presse Med. 2001;30:1044\u20137.","journal-title":"Presse Med"},{"issue":"2004","key":"600_CR43","first-page":"113","volume":"34","author":"M Campbell","year":"2003","unstructured":"Campbell M, Thomson S, Ramsay C, MacLennan G, Grimshaw J. Sample size calculator for cluster randomized trials. Comput Biol Med. 2003;34(2004):113\u201325.","journal-title":"Comput Biol Med"},{"key":"600_CR44","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1002\/sim.4780030302","volume":"3","author":"A Donner","year":"1984","unstructured":"Donner A. Approaches to sample size estimation in the design of clinical trials - a review. Stat Med. 1984;3:199\u2013214.","journal-title":"Stat Med"},{"key":"600_CR45","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1136\/bmj.330.7495.843","volume":"330","author":"D Altman","year":"2005","unstructured":"Altman D, Bland J. Treatment allocation by minimisation. BMJ. 2005;330:843.","journal-title":"BMJ"},{"key":"600_CR46","unstructured":"Barnet V, Lewis T. Outliers in statistical data. 3rd Edition. Chichester: John Wiley & Sons; 1994."},{"key":"600_CR47","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1136\/bmj.316.7124.54","volume":"316","author":"S Kerry","year":"1998","unstructured":"Kerry S, Bland J. Analysis of a trial randomised in clusters. BMJ. 1998;316:54.","journal-title":"BMJ"},{"key":"600_CR48","doi-asserted-by":"crossref","unstructured":"Lang T, Secic M. How to report statistics in medicine. Philadelphia: American College of Physicians; 1997.","DOI":"10.1097\/00006205-199705000-00022"},{"issue":"3","key":"600_CR49","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1370\/afm.41","volume":"2","author":"J Reed","year":"2004","unstructured":"Reed J. Adjusted Chi-Square statistics: application to clustered binary data in primary care. Ann Family Med. 2004;2(3):201\u20133.","journal-title":"Ann Family Med"},{"key":"600_CR50","first-page":"339","volume":"5","author":"J Mollison","year":"2000","unstructured":"Mollison J, Simpson J, Campbell M, Grimshaw J. Comparison of analytical methods for cluster randomized trials: an example from a primary care setting. J Epid Biostat. 2000;5:339\u201348.","journal-title":"J Epid Biostat"},{"key":"600_CR51","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/0895-4356(95)00511-0","volume":"49","author":"A Donner","year":"1996","unstructured":"Donner A, Klar N. Statisticial considerations in the design and analysis of community intervention risk. J Clin Epidemiol. 1996;49:435\u20139.","journal-title":"J Clin Epidemiol"},{"issue":"1","key":"600_CR52","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1037\/a0026971","volume":"17","author":"S Liu","year":"2012","unstructured":"Liu S, Rovine MJ, Molenaar PC. Selecting a linear mixed model for longitudinal data: repeated measures analysis of variance, covariance pattern model, and growth curve approaches. Psychol Methods. 2012;17(1):15\u201330.","journal-title":"Psychol Methods"},{"key":"600_CR53","unstructured":"Hill C, Com-Nougu\u00e9 C, Kramar A, et al. Analyse statistique des donn\u00e9es de survie. Paris: Flammarion M\u00e9decine et science Ed; 1996."}],"container-title":["BMC Geriatrics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12877-017-0600-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,2]],"date-time":"2019-10-02T19:15:11Z","timestamp":1570043711000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmcgeriatr.biomedcentral.com\/articles\/10.1186\/s12877-017-0600-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8,30]]},"references-count":53,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["600"],"URL":"https:\/\/doi.org\/10.1186\/s12877-017-0600-7","relation":{},"ISSN":["1471-2318"],"issn-type":[{"value":"1471-2318","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,8,30]]},"article-number":"195"}}